HTGF exits Cytena in €30.25m deal
High-Tech Gründerfonds (HTGF) and private investors in single-cell technology company Cytena have sold all shares to trade buyer Cellink for €30.25m.
More on Exits
Levine Leichtman sells stake in ZorgDomein
Rabobank is to acquire a 34% stake in the healthcare platform via its Corporate Investments arm
Sagard buys Nutrisens from Evolem, Unigrains
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Litorina-backed Fractal Gaming Group to list
Intention to list comes four years after the GP acquired the company via its fourth fund
IBB, Picus-backed Getsurance sold to trade
Insurtech company raised €2m in 2017 from Picus Capital and IBB but filed for insolvency in 2020
Latest News
Levine Leichtman sells stake in ZorgDomein
Rabobank is to acquire a 34% stake in the healthcare platform via its Corporate Investments arm
Sagard buys Nutrisens from Evolem, Unigrains
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Litorina-backed Fractal Gaming Group to list
Intention to list comes four years after the GP acquired the company via its fourth fund
VC-backed Mister Spex buys Tribe
Online optician has previously received VC funding from investors including Grazia Equity and Goldman Sachs